A decreasing trend was observed for nanoconjugates relative to low molecular weight iron chelators (DFO, DFX, and DFP), although it is not significantly different ( Figure S11 ).
← all excerpts
Design of Safe Nanotherapeutics for the Excretion of Excess Systemic Toxic Iron.
1
—
—